(MedPage Today) — The use of potent aldehyde dehydrogenase 1 A1 (ALDH1A1)-activating proton pump inhibitors (PA-PPIs) was associated with inferior survival outcomes in patients with newly diagnosed glioblastoma, according to a retrospective meta…
Source link : https://www.medpagetoday.com/hematologyoncology/braincancer/118707
Author :
Publish date : 2025-11-25 16:55:00
Copyright for syndicated content belongs to the linked Source.
